In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with John Ross, President at Mayne Pharma US. John Ross has spent 15 years in the pharma contract services space in senior roles following some time at Eli Lilly and PWC. He joined Mayne in 2013 as a VP and transitioned to President in 2017. Today, he oversees over 550+ people in North Carolina and has managed a huge injection of investment in the business.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest John Ross, covering the contrast from working in Big Pharma versus running high-growth contract service organisations. They also discuss the increasing demand for and challenge of handling, developing and manufacturing highly potent pharmaceutical products. Lastly they trade tips for leading a senior management team in a global business while also making time to learn and balance life outside of work. 

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.